One Week Aligner Evaluation
Launched by ALIGN TECHNOLOGY, INC. · Nov 10, 2015
Trial Information
Current as of July 08, 2025
Completed
Keywords
ClinConnect Summary
The Invisalign® System consists of a series of clear plastic aligners that are intended to replace conventional wire and bracket technology for many orthodontic cases. Each custom manufactured aligner exerts gentle, continuous forces to move teeth incrementally from their original state to a final, treated state. The aligners are designed to optimally move each tooth at a speed that follows physiologic principles. The purpose of this study is to demonstrate that changing aligners weekly provides similar results to changing aligners every two weeks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject must have fully erupted dentition except for 2nd and 3rd molars
- • For Teen treatment group, subjects ages \<17 years of age
- • For Adult treatment group, subjects ≥17 years of age
- Exclusion Criteria:
- • Subject has undergone any accelerated orthodontic treatment prior to or during treatment as part of this study
- • Subject with active caries
- • Subject with periodontal disease
- • Subject with TMD symptoms
- • Subject has known allergy to latex or plastic
- • Subjects who are pregnant or will become pregnant during treatment
About Align Technology, Inc.
Align Technology, Inc. is a leading global medical device company specializing in the design, manufacture, and marketing of innovative orthodontic products and services. Renowned for its pioneering Invisalign clear aligner system, Align Technology leverages advanced 3D imaging and digital scanning technologies to provide orthodontic solutions that enhance patient outcomes and improve the efficiency of dental practices. With a commitment to research and development, Align Technology actively conducts clinical trials to advance its product offerings and explore new applications in dental and orthodontic care, ultimately aiming to transform the way orthodontics is delivered worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Jose, California, United States
Inver Grove Heights, Minnesota, United States
Maple Grove, Minnesota, United States
Livermore, California, United States
Napa, California, United States
San Francisco, California, United States
San Ramon, California, United States
Lone Tree, Colorado, United States
Merritt Island, Florida, United States
Pearl City, Hawaii, United States
Glen Carbon, Illinois, United States
Louisville, Kentucky, United States
Salisbury, Maryland, United States
Macomb, Michigan, United States
Burnsville, Minnesota, United States
Eden Prairie, Minnesota, United States
Carson City, Nevada, United States
Henderson, Nevada, United States
Marlton, New Jersey, United States
Mooresville, North Carolina, United States
Wilmington, North Carolina, United States
Oklahoma City, Oklahoma, United States
Seguin, Texas, United States
Brampton, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials